文献速递认知障碍与痴呆神经肌肉病

症状前C9orf72重复扩增携带者的认知与灰白质特征

Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion.
PubMed 文献 · Neurology · 2017-08-30

本研究纳入18例症状前C9orf72重复扩增携带者和15名无扩增的一级亲属对照,进行神经心理测试、T1加权MRI和弥散张量成像。结果显示携带者字母流畅性、Stroop卡片I和III得分较低,并伴有额叶、丘脑辐射及运动相关白质束完整性丧失;40岁以上携带者亚组出现丘脑、小脑及顶颞叶皮质灰质体积减少。未发现认知下降与灰白质改变的显著关联。

要点

  • 症状前C9orf72重复扩增携带者已出现执行功能与言语流畅性下降。
  • 白质完整性丧失见于额叶、丘脑辐射及运动相关纤维束。
  • 40岁以上携带者可见丘脑、小脑及顶颞叶皮质灰质萎缩。

核心结论

  • 症状前C9orf72重复扩增携带者已存在认知功能下降、白质完整性和灰质体积改变。
  • 神经心理评估、T1加权MRI和弥散张量成像可能有助于识别FTD或ALS症状前阶段的早期生物标志物。

研究设计与样本

  • 队列研究纳入18例症状前C9orf72重复扩增携带者和15名无致病扩增的一级亲属对照。
  • 所有受试者接受标准化神经心理测试、T1加权MRI和弥散张量成像。

主要发现

  • 与健康对照相比,症状前携带者字母流畅性、Stroop卡片I和Stroop卡片III得分较低。
  • 症状前携带者存在连接额叶、丘脑辐射及运动相关白质束的完整性丧失。
  • 40岁以上携带者亚组显示丘脑、小脑及顶叶和颞叶皮质灰质体积减少。
  • 未发现细微认知下降与灰质或白质改变之间的显著关系。

临床怎么用

  • 对C9orf72重复扩增携带者,可考虑神经心理评估联合T1加权MRI和弥散张量成像以早期识别脑改变。
  • 关注执行功能、言语流畅性及运动相关白质束完整性,作为症状前阶段的潜在监测指标。

局限性

  • 样本量较小(携带者18例,对照15例)。
  • 未发现认知下降与灰白质改变之间的显著关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate cognitive function, gray matter volume, and white matter integrity in the presymptomatic stage of chromosome 9 open reading frame 72 repeat expansion (C9orf72RE). METHODS: Presymptomatic C9orf72RE carriers (n = 18) and first-degree family members without a pathogenic expansion (healthy controls [HC], n = 15) underwent a standardized protocol of neuropsychological tests, T1-weighted MRI, and diffusion tensor imaging within our cohort study of autosomal dominant frontotemporal dementia (FTD). We investigated group differences in cognitive function, gray matter volume through voxel-based morphometry, and white matter integrity by means of tract-based spatial statistics. We correlated cognitive change with underlying gray or white matter. RESULTS: Our data demonstrate lower scores on letter fluency, Stroop card I, and Stroop card III, accompanied by white matter integrity loss in tracts connecting the frontal lobe, the thalamic radiation, and tracts associated with motor functioning in presymptomatic C9orf72RE compared with HC. In a subgroup of C9orf72RE carriers above 40 years of age, we found gray matter volume loss in the thalamus, cerebellum, and parietal and temporal cortex. We found no significant relationship between subtle cognitive decline and underlying gray or white matter. CONCLUSIONS: This study demonstrates that a decline in cognitive functioning, white matter integrity, and gray matter volumes are present in presymptomatic C9orf72RE carriers. These findings suggest that neuropsychological assessment, T1-weighted MRI, and diffusion tensor imaging might be useful to identify early biomarkers in the presymptomatic stage of FTD or amyotrophic lateral sclerosis.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Papma JM, Jiskoot LC, Panman JL, et al. Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansion. Neurology. 2017. PMID: 28855404. doi:10.1212/WNL.0000000000004393

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。